(MDAXEX) iShares MDAX (DE) CHF - Ratings and Ratios
Stocks, Equities, SmallCap, MidCap, GermanCompanies
Description: MDAXEX iShares MDAX (DE) CHF
The iShares MDAX UCITS ETF (DE) CHF, traded as MDAXEX, is an exchange-traded fund (ETF) that tracks the MSCI Germany Small Cap NR EUR index, providing investors with exposure to small-cap German equities. As a Switzerland-originated ETF, it falls under the Germany Small/Mid-Cap Equity category.
From a performance perspective, the ETF has shown resilience, with its current price hovering around its 20-day Simple Moving Average (SMA). The 50-day and 200-day SMAs indicate a longer-term uptrend, suggesting the ETF has been performing well over the past few months. The Average True Range (ATR) indicates moderate volatility, which may be a consideration for risk-averse investors.
Key Performance Indicators (KPIs) to monitor for this ETF include its tracking error relative to the MSCI Germany Small Cap NR EUR index, expense ratio, and trading volume. A low tracking error and expense ratio would indicate efficient index replication and cost-effectiveness. High trading volume is also desirable as it implies liquidity, making it easier to buy or sell shares without significantly affecting the price.
With Assets Under Management (AUM) of approximately CHF 5.93 billion, the ETF demonstrates a significant presence in the market, which can contribute to liquidity and potentially tighter bid-ask spreads. Investors should also consider the sectoral and market capitalization distribution within the ETF to ensure alignment with their investment objectives and risk tolerance.
To make an informed investment decision, its essential to evaluate the ETFs historical performance during different market conditions, its correlation with other assets in the investors portfolio, and the overall economic outlook for Germanys small-cap sector. This analysis will help in determining whether the iShares MDAX UCITS ETF (DE) CHF is a suitable addition to an investment portfolio.
Additional Sources for MDAXEX ETF
MDAXEX ETF Overview
Market Cap in USD | 7,453,007m |
Category | Germany Small/Mid-Cap Equity |
IPO / Inception | 2001-04-19 |
MDAXEX ETF Ratings
Growth Rating | -8.48 |
Fundamental | - |
Dividend Rating | 8.51 |
Rel. Strength | 0.61 |
Analysts | - |
Fair Price Momentum | 223.70 CHF |
Fair Price DCF | - |
MDAXEX Dividends
Currently no dividends paidMDAXEX Growth Ratios
Growth Correlation 3m | 73.7% |
Growth Correlation 12m | 74.7% |
Growth Correlation 5y | -70.7% |
CAGR 5y | -0.86% |
CAGR/Max DD 5y | -0.02 |
Sharpe Ratio 12m | 0.62 |
Alpha | 4.57 |
Beta | 0.668 |
Volatility | 16.30% |
Current Volume | 1.2k |
Average Volume 20d | 0.1k |
Stop Loss | 227.7 (-3.5%) |
As of July 15, 2025, the stock is trading at CHF 235.95 with a total of 1,161 shares traded.
Over the past week, the price has changed by +0.32%, over one month by +2.41%, over three months by +16.43% and over the past year by +14.07%.
Neither. Based on ValueRay´s Analyses, iShares MDAX (DE) CHF is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -8.48 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MDAXEX is around 223.70 CHF . This means that MDAXEX is currently overvalued and has a potential downside of -5.19%.
iShares MDAX (DE) CHF has no consensus analysts rating.
According to our own proprietary Forecast Model, MDAXEX iShares MDAX (DE) CHF will be worth about 255.2 in July 2026. The stock is currently trading at 235.95. This means that the stock has a potential upside of +8.17%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 255.2 | 8.2% |